Literature DB >> 2227810

Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections.

A Francavilla1, C Panella, L Polimeno, A Giangaspero, V Mazzaferro, C E Pan, D H Van Thiel, T E Starzl.   

Abstract

Thirteen patients who underwent 40% to 80% removal of their livers had blood samples drawn initially and daily on postoperative days 1 to 7. The enzyme marker of heightened polyamine metabolism, ornithine decarboxylase, and the indicator of DNA synthesis, thymidine kinase, were measured. In addition, the hormones (insulin, glucagon, estradiol and androgen), which in animals are known to reflect and possibly modulate regeneration, were measured. Changes in all these indices followed the same pattern as in rats, dogs and swine but at a slower rate. Ornithine decarboxylase and estradiol increased within 24 hr, but thymidine kinase and insulin rises did not become statistically significant until 3 to 5 days. Using these plasma or serum indices as surrogate measures of biochemical events in the liver itself, regeneration reached a maximum after 4 or 5 days. By computed tomography scan analysis, restoration of hepatic cell mass was not complete until 3 wk.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227810      PMCID: PMC2952466          DOI: 10.1002/hep.1840120510

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Regeneration of the liver.

Authors:  K WEINBREN
Journal:  Gastroenterology       Date:  1959-11       Impact factor: 22.682

2.  Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse.

Authors:  S Yoshimura; N Kamada
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Regulation of thymidine kinase synthesis in human cells.

Authors:  L J Bello
Journal:  Exp Cell Res       Date:  1974-12       Impact factor: 3.905

4.  In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques.

Authors:  D H Van Thiel; N G Hagler; R R Schade; M L Skolnick; A P Heyl; E Rosenblum; J S Gavaler; R J Penkrot
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

5.  Regenerating rat liver: correlations between estrogen receptor localization and deoxyribonucleic acid synthesis.

Authors:  A Francavilla; A di Leo; P K Eagon; S Q Wu; P Ove; D H van Thiel; T E Starzl
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

6.  Transforming growth factor-alpha stimulates proto-oncogene c-jun expression and a mitogenic program in primary cultures of adult rat hepatocytes.

Authors:  D A Brenner; K S Koch; H L Leffert
Journal:  DNA       Date:  1989-05

7.  Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.

Authors:  F J Dudley; F P Alford; D J Chisholm; D M Findlay
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

8.  Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver.

Authors:  J A McGowan; N Fausto
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

9.  Optimized assay for thymidine kinase and its application to the detection of antibodies against herpes simplex virus type 1- and 2-induced thymidine kinase.

Authors:  J S Gronowitz; C F Källander
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Relationship between plasma and hepatic cytosolic levels of ornithine decarboxylase (ODC) and thymidine kinase (TK) in 70% hepatectomized rats.

Authors:  L Polimeno; A Azzarone; P Dell'Aquila; C Amoruso; M Barone; A Angelini; D H Van Thiel; A Francavilla
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

View more
  7 in total

1.  Cyclin D1 regulates hepatic estrogen and androgen metabolism.

Authors:  Lisa K Mullany; Eric A Hanse; Andrea Romano; Charles H Blomquist; J Ian Mason; Bert Delvoux; Chelsea Anttila; Jeffrey H Albrecht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-25       Impact factor: 4.052

2.  Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration.

Authors:  A Francavilla; Q Zeng; L Polimeno; B I Carr; D Sun; K A Porter; D H Van Thiel; T E Starzl
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

3.  Baboon-to-human liver transplantation.

Authors:  T E Starzl; J Fung; A Tzakis; S Todo; A J Demetris; I R Marino; H Doyle; A Zeevi; V Warty; M Michaels
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

4.  Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.

Authors:  F Xue; T Takahara; Y Yata; Y Kuwabara; E Shinno; K Nonome; M Minemura; S Takahara; X Li; E Yamato; A Watanabe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

5.  Relationship between plasma and hepatic cytosolic levels of ornithine decarboxylase (ODC) and thymidine kinase (TK) in 70% hepatectomized rats.

Authors:  L Polimeno; A Azzarone; P Dell'Aquila; C Amoruso; M Barone; A Angelini; D H Van Thiel; A Francavilla
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

6.  Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.

Authors:  Saireudee Chaturantabut; Arkadi Shwartz; Kimberley J Evason; Andrew G Cox; Kyle Labella; Arnout G Schepers; Song Yang; Mariana Acuña; Yariv Houvras; Liliana Mancio-Silva; Shannon Romano; Daniel A Gorelick; David E Cohen; Leonard I Zon; Sangeeta N Bhatia; Trista E North; Wolfram Goessling
Journal:  Gastroenterology       Date:  2019-01-12       Impact factor: 22.682

7.  Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.

Authors:  S Rehn; J S Gronowitz; C Källander; C Sundström; B Glimelius
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.